Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippia finds jobs where you're a top candidate and applies on your behalf.
Integra LifeSciences's peak revenue was $1.6B in 2024. The peak quarterly revenue was $442.6M in 2024(q4).
Integra LifeSciences's revenue increased from $277.9m in 2005 to $1.6B currently. That's a 479.46% change in annual revenue.
| Fiscal year / year | Integra LifeSciences revenue |
|---|---|
| 2009 | $682.5M |
| 2010 | $732.1M |
| 2011 | $780.1M |
| 2012 | $830.9M |
| 2013 | $696.8M |
| 2014 | $796.7M |
| 2015 | $882.7M |
| 2016 | $992.1M |
| 2017 | $1.2B |
| 2018 | $1.5B |
| 2019 | $1.5B |
| 2020 | $1.4B |
| 2021 | $1.5B |
| 2022 | $1.6B |
| 2023 | $1.5B |
| 2024 | $1.6B |
Rate Integra LifeSciences' financial transparency
Integra LifeSciences saw the greatest revenue growth in 2006, when revenue increased by 50.86%.
Integra LifeSciences had the lowest revenue growth in 2013, when revenue changed by -16.13%.
| Year | Integra LifeSciences growth |
|---|---|
| 2009 | 4%↑ |
| 2010 | 7%↑ |
| 2011 | 7%↑ |
| 2012 | 7%↑ |
| 2013 | -16%↓ |
| 2014 | 14%↑ |
| 2015 | 11%↑ |
| 2016 | 12%↑ |
| 2017 | 20%↑ |
| 2018 | 24%↑ |
| 2019 | 3%↑ |
| 2020 | -10%↓ |
| 2021 | 12%↑ |
| 2022 | 1%↑ |
| 2023 | -1%↓ |
| 2024 | 4%↑ |
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2009 | $161.0M | $165.7M | $172.3M | $183.5M |
| 2010 | $172.7M | $178.6M | $186.6M | $194.1M |
| 2011 | $181.0M | $193.3M | $202.2M | $203.5M |
| 2012 | $196.2M | $210.2M | $210.1M | $214.4M |
| 2013 | $196.7M | $205.5M | $213.2M | $81.4M |
| 2014 | $215.1M | $231.4M | $197.5M | $219.1M |
| 2015 | $202.5M | $212.7M | $226.4M | $241.2M |
| 2016 | $236.8M | $249.3M | $250.3M | $255.7M |
| 2017 | $258.6M | $282.2M | $278.8M | $368.6M |
| 2018 | $357.1M | $366.2M | $365.9M | $383.3M |
| 2019 | $359.7M | $383.6M | $379.1M | $395.1M |
| 2020 | $354.3M | $258.7M | $370.2M | $388.6M |
| 2021 | $360.1M | $390.0M | $386.9M | $405.5M |
| 2022 | $376.6M | $397.8M | $385.2M | $398.0M |
| 2023 | $380.8M | $381.3M | $382.4M | $397.0M |
| 2024 | $368.9M | $418.2M | $380.8M | $442.6M |
Do you work at Integra LifeSciences?
Did Integra LifeSciences meet its revenue projections?
| CEO | Jan D. de Witte |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 3,700 |
| Date Founded | 1989 |
| Headquarters | Plainsboro, New Jersey |
| Number of Locations | 9 |
| Revenue | $1.6B |
| Net Income | $180,550,000 |
| Gross Proft | $882.1M (2024) |
| EBITDA | $53.6M (2024) |
| PE Ratio | -581.57 |
| Tax Rate | 0.6% |
| Market Capitalization | $4.0B |
| Total Assets | $3,889,758,000 |
| Ticker | IART |
Integra LifeSciences received early financing of $350.0M on 2018-05-15.
| Series | Round size | Date |
|---|---|---|
| Post Ipo Equity | $350M | 05/2018 |
Integra LifeSciences's top competitor, Stryker, earned an annual revenue of $22.6B.
Integra LifeSciences's smallest competitor is LifeScan with revenue of $1.5B last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Medtronic | $73,671 | $17.0B | 104,950 | 1,891 |
| Teleflex | $53,771 | $3.0B | 14,000 | 141 |
| Stryker | $69,470 | $22.6B | 43,000 | 1,903 |
| MDxHealth | $68,981 | $5.9M | 171 | 5 |
| Zimmer Biomet | $57,475 | $7.7B | 18,200 | 384 |
| PerkinElmer | $85,448 | $2.8B | 14,000 | 141 |
| Luminex | $73,985 | $417.4M | 1,140 | 5 |
| Philips Healthcare | $85,358 | $6.8B | 24,000 | 178 |
| CyLex | $77,521 | $3.1M | 200 | - |
| Bio-Rad Laboratories | $93,296 | $2.8B | 8,250 | 69 |
Zippia gives an in-depth look into the details of Integra LifeSciences, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Integra LifeSciences. The employee data is based on information from people who have self-reported their past or current employments at Integra LifeSciences. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Integra LifeSciences. The data presented on this page does not represent the view of Integra LifeSciences and its employees or that of Zippia.
Integra LifeSciences may also be known as or be related to Integra LifeSciences, Integra LifeSciences Corp, Integra LifeSciences Corporation, Integra LifeSciences Holdings Corporation, Integra Lifesciences Holdings Corporation and Integra lifesciences.